Hitoshi Kiyoi

23PUBLICATIONS
90CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Aug 14, 2026
ELTS Score and Early "Warning" Define a Two-Stage Risk Framework for Failure-Free Survival in Chronic-Phase CML.

|Jun 18, 2026
Treatment-free remission and immune profiling after frontline second-generation TKI therapy in CML.

|Jun 11, 2026
Early predictors of MR4.5 attainment and eligibility for TKI discontinuation in CML treated with second-generation TKIs.

|Apr 07, 2026
Ponatinib inhibits LCK and PI3K signaling and promotes CD8+ T stem cell memory cell development.

Yuki Okuhiro, Sachiko Ito, Keisuke Watanabe

|Jan 07, 2026
NUP98 rearrangements in adult AML patients: evaluation of clinical implications and identification of novel fusion partners.

Kazuhisa Chonabayashi, Makoto Iwasaki, Junya Kanda

|Dec 10, 2024
Cullin-5 deficiency promotes chimeric antigen receptor T cell effector functions potentially via the modulation of JAK/STAT signaling pathway.

Yoshitaka Adachi, Seitaro Terakura, Masahide Osaki

Pageof 4

Frequent Collaborators

7 joint publications

Itaru Matsumura

5 joint publications

Emiko Sakaida

5 joint publications

Naoto Takahashi

5 joint publications

Shigeki Ohtake